Laboratories

Publications

Update : 2023-05-10

Contents

  1. Original articles
  2. Reviews and book chapters

Original articles

2023

Takahashi M, Okamoto Y, Kato Y, Shirahama H, Tsukahara S, Sugimoto Y, Tomida A.
Activating mutations in EGFR and PI3K promote ATF4 induction for NSCLC cell survival during amino acid deprivation.
Heliyon, 9, e14799 (2023)

2022

Kunimasa K, Ikeda-Ishsikawa C, Tani Y, Tsukahara S, Sakurai J, Okamoto Y, Koido M, Dan S, Tomida A.
Spautin-1 inhibits mitochondrial complex I and leads to suppression of the unfolded protein response and cell survival during glucose starvation.
Sci Rep, 12, 11533 (2022)

2021

Iwao Y, Okamoto Y, Shirahama H, Tsukahara S, Tomida A.
eIF4B enhances ATF4 expression and contributes to cellular adaptation to asparagine limitation in BRAF-mutated A375 melanoma.
Biochem Biophys Res Commun, 573, 93-99 (2021)
Nishiya N, Oku Y, Ishikawa C, Fukuda T, Dan S, Mashima T, Ushijima M, Furukawa Y, Sasaki Y, Otsu K, Sakyo T, Abe M, Yonezawa H, Ishibashi F, Matsuura M, Tomida A, Seimiya H, Yamori T, Iwao M, Uehara Y.
Lamellarin 14, a derivative of marine alkaloids, inhibits the T790M/C797S mutant epidermal growth factor receptor.
Cancer Sci, 112, 1963-1974 (2021)

2020

Kato Y, Kunimasa K, Takahashi M, Harada A, Nagasawa I, Osawa M, Sugimoto Y, Tomida A.
GZD824 Inhibits GCN2 and Sensitizes Cancer Cells to Amino Acid Starvation Stress.
Mol Pharmacol, 98, 669-676 (2020)
Nagasawa I, Koido M, Tani Y, Tsukahara S, Kunimasa K, Tomida A.
Disrupting ATF4 Expression Mechanisms Provides an Effective Strategy for BRAF-Targeted Melanoma Therapy.
iScience, 23,101028 (2020)
Okamoto Y, Saito T, Tani Y, Toki T, Hasebe A, Koido M, Tomida A
The kinase PERK represses translation of the G-protein-coupled receptor LGR5 and receptor tyrosine kinase ERBB3 during ER stress in cancer cells.
J Biol Chem, 295, 4591-4603 (2020)

2018

Kato Y, Kunimasa K, Sugimoto Y, Tomida A.
BCR-ABL tyrosine kinase inhibition induces metabolic vulnerability by preventing the integrated stress response in K562?cells.
Biochem Biophys Res Commun, 504, 721-726 (2018)
Koido M, Tani Y, Tsukahara S, Okamoto Y, Tomida A.
InDePTH: detection of hub genes for developing gene expression networks under anticancer drug treatment.
Oncotarget, 9, 29097-29111 (2018)

2017

Koido M, Haga N, Furuno A, Tsukahara S, Sakurai J, Tani Y, Sato S, Tomida A.
Mitochondrial deficiency impairs hypoxic induction of HIF-1 transcriptional activity and retards tumor growth.
Oncotarget, 8,11841-11845, (2017)
Nagasawa I, Kunimasa K, Tsukahara S, Tomida A.
BRAF-mutated cells activate GCN2-mediated integrated stress response as a cytoprotective mechanism in response to vemurafenib.
Biochem Biophys Res Commun, 482, 1491-1497 (2017)

このページのTOPへ

2016

Koido M, Sakurai J, Tsukahara S, Tani Y, Tomida A.
PMEPA1, a TGF-β- and hypoxia-inducible gene that participates in hypoxic gene expression networks in solid tumors.
Biochem Biophys Res Commun, 479, 615-621(2016)
Tsukumo, Y., Tsukahara, S., Furuno, A., Iemura, S.I., Natsume, T., Tomida, A.
TBL2 associates with ATF4 mRNA via its WD40 domain and regulates its translation during ER stress.
J Cell Biochem, 117, 500-509 (2016)

このページのTOPへ

2015

Mashima, T., Ushijima, M., Matsuura, M., Tsukahara, S., Kunimasa, K., Furuno, A., Saito, S., Kitamura, M., Soma-Nagae, T., Seimiya, H., Dan, S., Yamori, T., Tomida, A.
Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation.
Cancer Sci, 106, 909-920 (2015)
Tsukumo, Y., Tsukahara, S., Furuno, A., Iemura, S., Natsume, T., Tomida, A.
The endoplasmic reticulum-localized protein TBL2 interacts with the 60S ribosomal subunit.
Biochem Biophys Res Commun, 462, 383-388 (2015)

このページのTOPへ

2014

Matsumura, S., Yuge, R., Sato, S., Tomida, A., Ichihashi, T., Irie, H., Iijima, S., Shiba, K., Yudasaka, M.
Ultrastructural localization of intravenously injected carbon nanohorns in tumor.
Int J Nanomedicine, 9, 3499-3508 (2014)
Migita, T., Okabe, S., Ikeda, K., Igarashi, S., Sugawara, S., Tomida, A., Soga, T., Taguchi, R., Seimiya, H.
Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells.
Int J Cancer, 135, 37-47 (2014)
Tsukumo, Y., Tsukahara, S., Furuno, A., Iemura, S., Natsume, T., Tomida, A.
TBL2 is a novel PERK-binding protein that modulates stress-signaling and cell survival during endoplasmic reticulum stress.
PLoS One, 9, e112761 (2014)

このページのTOPへ

2013

Ushijima, M., Mashima, T., Tomida, A., Dan, S., Saito, S., Furuno, A., Tsukahara, S., Seimiya, H., Yamori, T., Matsuura, M.
Development of a gene expression database and related analysis programs for evaluation of anticancer compounds.
Cancer Sci, 104, 360-368 (2013)
Migita, T., Okabe, S., Ikeda, K., Igarashi, S., Sugawara, S., Tomida, A., Taguchi, R., Soga, T., Seimiya, H.
Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact.
Am J Pathol, 182, 1800-1820 (2013)

このページのTOPへ

2012

Saito, S., Furuno, A., Sakurai, J., Park, H-R., Shin-ya, K., Tomida, A.
Compound C prevents the unfolded protein response during glucose deprivation through a mechanism independent of AMPK and BMP signaling.
PLoS ONE, 7, e45845 (2012)
Matsuo, J., Tsukumo, Y., Saito, S., Tsukahara, S., Sakurai, J., Sato, S., Kondo, H., Ushijima, M., Matsuura, M., Watanabe, T., Tomida, A.
Hyperactivation of 4E-binding protein 1 as a mediator of biguanide-induced cytotoxicity during glucose deprivation.
Mol Cancer Ther, 11, 1082-1091 (2012)

このページのTOPへ

2011

Awale, S., Linn, T.Z., Li, F., Tezuka, Y., Myint, A., Tomida, A., Yamori, T., Esumi, H., Kadota, S.
Identification of Chrysoplenetin from Vitex negundo as a Potential Cytotoxic Agent against PANC-1 and a Panel of 39 Human Cancer Cell Lines (JFCR-39).
Phytother Res, 25, 1770-1775 (2011)
Saito, S., Tomida, A.
Use of chemical genomics in assessment of the UPR.
Methods Enzymol, 491, 327-341 (2011)

このページのTOPへ

2010

Haga, N., Saito, S., Tsukumo, Y., Sakurai, J., Furuno, A., Tsuruo, T., Tomida, A.
Mitochondria regulate the unfolded protein response leading to cancer cell survival under glucose deprivation conditions.
Cancer Sci, 101, 1125-1132 (2010)
Kim, J.Y., Hwang, J.H., Cha, M.R., Yoon, M.Y., Son, E.S., Tomida, A., Ko, B., Song, S.W., Shin-Ya, K., Hwang, Y.I., Park, H.R.
Arctigenin blocks the unfolded protein response and shows therapeutic antitumor activity.
J Cell Physiol, 224, 33-40 (2010)
Misawa, A., Katayama, R., Koike, S., Tomida, A., Watanabe, T., Fujita, N.
AP-1-Dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP cells.
Oncol Res, 19, 23-33 (2010)

このページのTOPへ

2009

Arnaudeau, S., Arboit, P., Bischof, P., Shin-ya, K., Tomida, A., Tsuruo, T., Irion, O., Cohen, M.
Glucose-regulated protein 78: a new partner of p53 in trophoblast.
Proteomics, 9, 5316-5327 (2009)
Matsumura, S., Sato, S., Yudasaka, M., Tomida, A., Tsuruo, T., Iijima, S., Shiba, K.
Prevention of carbon nanohorn agglomeration using a conjugate composed of comb-shaped polyethylene glycol and a peptide aptamer.
Mol Pharm, 6, 441-447 (2009)
Matsuo, J., Tsukumo, Y., Sakurai, J., Tsukahara, S., Park, H.R., Shin-Ya, K., Watanabe, T., Tsuruo, T., Tomida, A.
Preventing the unfolded protein response via aberrant activation of 4E-binding protein 1 by versipelostatin.
Cancer Sci, 100, 327-333 (2009)
Miyawaki, J., Matsumura, S., Yuge, R., Murakami, T., Sato, S., Tomida, A., Tsuruo, T., Ichihashi, T., Fujinami, T., Irie, H., Tsuchida, K., Iijima, S., Shiba, K., Yudasaka, M.
Biodistribution and ultrastructural localization of single-walled carbon nanohorns determined in vivo with embedded Gd2O3 labels.
ACS Nano, 3, 1399-1406 (2009)
Saito, S., Furuno, A., Sakurai, J., Sakamoto, A., Park, H.R., Shin-Ya, K., Tsuruo, T., Tomida, A.
Chemical genomics identifies the unfolded protein response as a target for selective cancer cell killing during glucose deprivation.
Cancer Res, 69, 4225-4234 (2009)
Tsukumo, Y., Tsukahara, S., Saito, S., Tsuruo, T., Tomida, A.
A novel endoplasmic reticulum export signal: proline at the +2-position from the signal peptide cleavage site.
J Biol Chem, 284, 27500-27510 (2009)
Yun, J., Kim, Y.I., Tomida, A., Choi, C.H.
Regulation of DNA topoisomerase IIalpha stability by the ECV ubiquitin ligase complex.
Biochem Biophys Res Commun, 389, 5-9 (2009)

このページのTOPへ

2008

Hwang, J.H., Kim, J.Y., Cha, M.R., Ryoo, I.J., Choo, S.J., Cho, S.M., Tsukumo, Y., Tomida, A., Shin-Ya, K., Hwang, Y.I., Yoo, I.D., Park, H.R.
Etoposide-resistant HT-29 human colon carcinoma cells during glucose deprivation are sensitive to piericidin A, a GRP78 down-regulator.
J Cell Physiol, 215, 243-250 (2008)
Isomura, M., Oya, N., Tachiiri, S., Kaneyasu, Y., Nishimura, Y., Akimoto, T., Hareyama, M., Sugita, T., Mitsuhashi, N., Yamashita, T., Aoki, M., Sai, H., Hirokawa, Y., Sakata, K., Karasawa, K., Tomida, A., Tsuruo, T., Miki, Y., Noda, T., Hiraoka, M.
IL12RB2 and ABCA1 genes are associated with susceptibility to radiation dermatitis.
Clin Cancer Res, 14, 6683-6689 (2008)
Sugita, H., Dan, S., Kong, D., Tomida, A., Yamori, T.
A new evaluation method for quantifying PI3K activity by HTRF assay.
Biochem Biophys Res Commun, 377, 941-945 (2008)
Wang, L., Bai, L., Nagasawa, T., Hasegawa, T., Yang, X., Sakai, J., Bai, Y., Kataoka, T., Oka, S., Hirose, K., Tomida, A., Tsuruo, T., Ando, M.
Bioactive triterpene saponins from the roots of Phytolacca americana.
J Nat Prod, 71, 35-40 (2008)

このページのTOPへ

2007

Hasegawa, T., Bai, J., Dai, J., Bai, L., Sakai, J., Nishizawa, S., Bai, Y., Kikuchi, M., Abe, M., Yamori, T., Tomida, A., Tsuruo, T., Hirose, K., Ando, M.
Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
Bioorg Med Chem Lett, 17, 3722-3728 (2007)
Hasegawa, T., Bai, J., Zhang, S., Wang, J., Matsubara, J., Kawakami, J., Tomida, A., Tsuruo, T., Hirose, K., Sakai, J., Kikuchi, M., Abe, M., Ando, M.
Structure-activity relationships of some taxoids as multidrug resistance modulator.
Bioorg Med Chem Lett, 17, 1122-1126 (2007)
Huang, L., Shitashige, M., Satow, R., Honda, K., Ono, M., Yun, J., Tomida, A., Tsuruo, T., Hirohashi, S., Yamada, T.
Functional interaction of DNA topoisomerase IIα with the β-catenin and T-cell factor-4 complex.
Gastroenterology, 133, 1569-1578 (2007)
Li, N., Wu, J.L., Hasegawa, T., Sakai, J., Bai, L.M., Wang, L.Y., Kakuta, S., Furuya, Y., Ogura, H., Kataoka, T., Tomida, A., Tsuruo, T., Ando, M.
Bioactive lignans from Peperomia duclouxii.
J Nat Prod, 70, 544-548 (2007)
Li, N., Wu, J.L., Hasegawa, T., Sakai, J., Bai, L.M., Wang, L.Y., Kakuta, S., Furuya, Y., Ogura, H., Kataoka, T., Tomida, A., Tsuruo, T., Ando, M.
Bioactive polyketides from Peperomia duclouxii.
J Nat Prod, 70, 998-1001 (2007)
Tsukumo, Y., Tomida, A., Kitahara, O., Nakamura, Y., Asada, S., Mori, K., Tsuruo, T.
Nucleobindin 1 controls the unfolded protein response by inhibiting ATF6 activation.
J Biol Chem, 282, 29264-29272 (2007)
Zhao, M., Bai, L., Wang, L., Toki, A., Hasegawa, T., Kikuchi, M., Abe, M., Sakai, J., Hasegawa, R., Bai, Y., Mitsui, T., Ogura, H., Kataoka, T., Oka, S., Tsushima, H., Kiuchi, M., Hirose, K., Tomida, A., Tsuruo, T., Ando, M.
Bioactive cardenolides from the stems and twigs of Nerium oleander.
J Nat Prod, 70, 1098-1103 (2007)

このページのTOPへ

2006

Dai, J., Bai, J., Hasegawa, T., Nishizawa, S., Sakai, J., Oka, S., Kiuchi, M., Hirose, K., Tomida, A., Tsuruo, T., Li, M., Ando, M.
A new taxoid from a callus culture of Taxus cuspidata as an MDR reversal agent.
Chem Pharm Bull (Tokyo), 54, 306-309 (2006)
Li, N., Wu, J.L., Hasegawa, T., Sakai, J., Wang, L.Y., Kakuta, S., Furuya, Y., Tomida, A., Tsuruo, T., Ando, M.
Bioactive dibenzylbutyrolactone and dibenzylbutanediol lignans from Peperomia duclouxii.
J Nat Prod, 69, 234-239 (2006)
Wu, J.L., Li, N., Hasegawa, T., Sakai, J., Mitsui, T., Ogura, H., Kataoka, T., Oka, S., Kiuchi, M., Tomida, A., Tsuruo, T., Li, M., Tang, W., Ando, M.
Bioactive secolignans from Peperomia dindygulensis.
J Nat Prod, 69, 790-794 (2006)

Return to Top of Page